Bain Capital Life Sciences Investors, LLC Replimune Group, Inc. Transaction History

Bain Capital Life Sciences Investors, LLC

  • $557 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$23.5 - $52.65 $49.9 Million - $112 Million
-2,122,415 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$18.85 - $27.0 $757,449 - $1.08 Million
-40,183 Reduced 1.86%
2,122,415 $48.9 Million
Q2 2020

Aug 14, 2020
SELL
$9.76 - $25.95 $6.6 Million - $17.6 Million
-676,370 Reduced 23.82%
2,162,598 $53.7 Million
Q3 2018

Nov 14, 2018
BUY
$14.99 - $22.14 $42.6 Million - $62.9 Million
2,838,968 New
2,838,968 $45.7 Million

Others Institutions Holding REPL

# of Institutions
149
Shares Held
68M
Call Options Held
52.3K
Put Options Held
80.3K
View Full List

About Replimune Group, Inc.

REPL Quotes by TradingView
  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $554M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email